David H.

David H. is a Principal Scientist at Allogene Therapeutics, with a strong background in cell engineering and molecular biology. Previously, David held the position of Senior Scientist at Synthego Corporation, where key achievements included the design of over 200 custom clonal cell lines using CRISPR-Cas9 and the establishment of standard operating procedures for large knock-in clones. David's academic journey culminated in a PhD in Biochemistry and Molecular Biology from the University of Southern California, where significant research included discovering enhancer-promoter interactions in mouse embryonic stem cells. Additional experience includes roles as a Patent Analyst, Technology Commercialization Intern, and teaching assistant at both the graduate and undergraduate levels.